Tag Archives: heart disease

Preventive Health Care – What is it really?

Preventive health care has gotten a lot of wind from the people running for President of the United States. Hillary Clinton says, “focus on prevention: wellness not sickness.” Mike Huckabee said that focusing on prevention “would save countless live, pain and suffereing by victims of chronic conditions, and billions of dollars.” Obama added that “too little is spent on prevention and public health.” But what is preventive health care.

According to the pharmaceutical industry, it would be statin drugs to prevent heart disease, except, it really doesn’t do that but they won’t admit to that. Screening tests, like blood and urine are deemed too costly because they are used willy nilly and expenisve procedures like MRIs and PET scans are way overused. In a recent (February 14th) issue of the New England Journal of Medicine, the Prospective omitted one type of prevention, nutrition.

Making our food supply real again would cut back on disease and would improve the quality of life more than anything out there. Eating real foods, not processed junk, would stem the tide of obesity, type II diabetes, heart disease and cancer yet they talk about everything else instead of the cause of high medical costs. Stop subsidizing big agriculture and helping them make things that have no business being called food is one way. Another, is to help educate Americans about what real food is.

Unfortunately, the government is not where this is going to happen. It will only happen when each and everyone of us makes a conscious choice at the supermarket to buy real food and avoid junk. The dollar speaks mightier than the legislative pen. Buy organic, buy local, buy real.

Cholesterol Lowering Drugs are Worthless in Most Cases – Part Two

This past Friday, I talked about the issues with Lipitor® and the lack of the association between high cholesterol and coronary heart disease. Now let’s talk about real problems that comes up by taking this drug.

Say the side-effect rate is 3-5% (which is the pharmaceutical industry line) which means that given one-percent of people get a benefit, five-percent get side-effects that can be rather serious. Guess what? That estimate is way under what practitioners in the field are seeing. Reports indicate that in the real world the side-effect rate is closer to 15%.

Obviously, this would mean that we need to move away from pharmaceutical intervention to lower cholesterol to alternative, “natural” ones right? Wrong. Turns out cholesterol levels in people with heart disease are not really much higher than people without heart disease. Also, low cholesterol (under 160mg/dl) may increase the risk of a number of health disorders like stroke, cancer, depression, and suicide. Lowering cholesterol is not the issue, in spite of what the nutraceutical industry would like you to believe. They are being no different in their claims than the pharmaceutical industry.

The real culprit in heart disease is inflammation. Lower inflammation and not only do you lower the real risk for heart disease , you lower the risks for a myriad of other diseases from diabetes to arthritis, from cancer to migraines, seizures and irritable bowel syndrome to name a few.

In tomorrow’s blog, I will discuss tools that will help you determine your level of inflammation along with things you can do to alleviate it.

Cholesterol Lowering Drugs are Worthless in Most Cases – Part One

Some of you may have noticed a lack of posts from me this week well I have a pretty good reason. My 86-year old father underwent triple-bypass surgery due to three 90%+ clogged arteries. Since this makes two parents out of two having this dangerous procedure, I wanted to research heart disease a bit. Then I saw an article in Business Week magazine while walking through the SeaTac Airport that made me smile as it was saying what I have been saying for years, which is, statin drugs really don’t prevent heart disease.  

Aside from the Vytorin®/Zetia® debacle, the whole idea of lowering cholesterol (LDL especially) to prevent heart disease is nothing less than a scam. In my upcoming book, Achieving Victory Over a Toxic World, I devote a few pages on the medical communities fascination with LDL and heart disease and how bogus the idea is. Well, the evidence is coming in that I was indeed right, as were a number of researchers I mentioned like Dr. Ufe Ravnskov and Dr. John Abramson.

When I make my comments at lectures around the world about the lack of a real link between LDL cholesterol and heart disease I get mixed reactions. Knowledgeable health care practitioners nod in agreement with big smiles; others grimace with a backdrop of anger and disbelief. Individuals look mystified, bewildered and highly skeptical. How can a guy with a doctorate in business be right when so many physicians who have studied heart disease be wrong? If you stay on the side that thinks statin drugs and lowering cholesterol are proven preventive treatments for coronary heart disease after reading this three-part blog, either you are in a major state of denial or you are on the payroll of a pharmaceutical company that is benefiting from the sale of these ill-conceived toxins.

An important concept to understand is a number called the NNT (Number Needed to Treat). This number tells us the number of people that must take a drug for one person to benefit. If a drug is perfect, than that number should be one, which means for every one person who takes the drug, one person will benefit from it and prevent or successfully treat the disease or syndrome.

For people taking an antibiotic cocktail to kill off the bacterium (H pylorii) that causes ulcers, the NNT is 1.1, which is pretty darn good.  For Lipitor®, whose sales last year for Pfizer was about 13 billion dollars, the NNT is between 16-23 for people who have had a heart attack or have definitive signs of heart disease. Not horrible, but an ok number.

So what does that number mean? To prevent one person having a heart event 16-23 people need to be taking the drug. To prevent a death, 48 people would have to take the drug for 5 years to save one life. But we are saving lives would (and is) the industry answer. Guess what? Change your lifestyle just a little bit (eat better, exercise more, stop smoking, etc) and you’ll do much better than that and you won’t have any nasty side effects.

For those of you with a risk factor like high blood pressure and no existing heart disease or heart attack history, the NNT goes to 75-200. If you have no risk factor except what the medical community would deem “high” cholesterol (over 220 mg/dl) the NNT is a ridiculous 500+ as there is no measurable reduction in deaths or serious events. Very little potential benefit, lots of profits for the pharmaceutical industry.

What about Zetia®? The NNT is an astounding 1000+. It is basically worthless. No benefits seen at all. The same can be said for the diabetes drug Avandia® which does lower blood glucose, but does not prevent any disease caused by diabetes.

“Lipitor® reduces the risk of heart attack by 36%… in patients with multiple risk factors for heart disease.” This is what Dr. Jarvik claims (as does Pfizer) in that insipid ad he appears on TV. Now let’s talk about the real numbers. In the clinical trial he mentions, three percent (3%) of the people taking placebo had a heart attack while two percent (2%) of the people taking Lipitor® had a heart attack. So, 99 people had to take Lipitor® for five years with no benefit for one person to gain a benefit over placebo to prevent a heart attack. I don’t know about you, but that isn’t a 36% improvement. Statistics lie when put into the hands of people with an agenda, especially a multi-billion dollar one.

Come back on Monday to find out how this is only the tip of the iceberg. On Tuesday I’ll be discussing the laboratory tests necessary to help prevent heart disease and help improve your overall cardiac health.

The Vytorin Scandal – Just the Tip of the Iceberg

Now with the scandal involving Scheering-Plough and Merck, two pharmaceutical giants becoming the biggest news story of the day I have to comment. Do you really think that the study that Vytorin is not beneficial is an isolated incident? If you do, you are sadly mistaken. When I worked for a company that sold clinical trial software to the pharmaceutical and medical device industry, I was involved in talking to a number of researchers employed by these companies and some of the things I heard made me realize that the focus of these companies was not your health but their profits.

Here are some of the details of the Vytorin story you may not know about.

  • The data that showed that Vytorin was not beneficial in the lowering of the risk of heart disease was known almost 2 years ago by people at Merck and Scheering-Plough.
  • The CEO of Merck ??? sold $29 million dollars worth of stock in her company last year, after she had to have known the results of the drug trial. 800,000 prescriptions a week are written for Vytorin which provides billions of dollars of profit to these two companies.
  • Worst of all, and something that Congress will be looking into is the fact that after the drug companies found out that Vytorin wasn’t showing up as well as expected they tried to manipulate the data to change the end points which would hopefully show the drug actually worked.

It is this last issue I have my greatest concerns about. When I taught a class to a medical device company in Cleveland, Ohio, I was asked by one of the primary investigators whether they could change the data once it was entered into the program. I made sure they understood that this would be illegal and immoral as well. Often times, I found out that many researchers (not all) in the pharmaceutical industry manipulate data end points and use other statistical machinations to create findings that are positive instead of properly studying results and reporting good and bad regardless of the financial ramifications.

With the recent research saying that there is no link between autism and thimerasol in mercury it was apparent that the researchers manipulated the end points to come up with a result they wanted to come up with. They claim that there was no relationship because there is no change in autism rates recently since thimerasol was removed from vaccines. Problem is that the number of years since the mercury laden vaccines have been removed are not sufficient to see a change in autism rates. Most autism is diagnosed at 4-5 but the removal of thimerasol was only done 2-3 years ago so how could they see a difference. This is known as changing the end point to create a result you want. It is immoral and dangerous.

It is time the FDA and our government do what they are charged with doing, protecting the citizens from dangerous drugs. The pharmaceutical industries money first attitude needs control and must be stopped. It is time for a major overhaul of the drug research and approval system.